First Horizon Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Sell |
2,331
-850
| -27% | -$104K | 0.01% | 438 |
|
|
2025
Q1 | $407K | Sell |
3,181
-58
| -2% | -$7.87K | 0.01% | 374 |
|
|
2024
Q4 | $428K | Buy |
3,239
+5
| +0.2% | +$703 | 0.01% | 361 |
|
|
2024
Q3 | $471K | Buy |
3,234
+4
| +0.1% | +$579 | 0.01% | 357 |
|
|
2024
Q2 | $443K | Hold |
3,230
| – | – | 0.01% | 350 |
|
|
2024
Q1 | $443K | Buy |
3,230
+1,037
| +47% | +$142K | 0.01% | 348 |
|
|
2023
Q4 | $298K | Buy |
2,193
+115
| +6% | +$14K | 0.01% | 409 |
|
|
2023
Q3 | $254K | Sell |
2,078
-87
| -4% | -$11.1K | 0.01% | 417 |
|
|
2023
Q2 | $275K | Sell |
2,165
-19
| -0.9% | -$2.47K | 0.01% | 426 |
|
|
2023
Q1 | $282K | Buy |
2,184
+173
| +9% | +$22.6K | 0.01% | 412 |
|
|
2022
Q4 | $264K | Sell |
2,011
-35
| -2% | -$4.52K | 0.01% | 405 |
|
|
2022
Q3 | $239K | Sell |
2,046
-132
| -6% | -$16.4K | 0.01% | 405 |
|
|
2022
Q2 | $256K | Buy |
2,178
+38
| +2% | +$4.51K | 0.01% | 428 |
|
|
2022
Q1 | $279K | Sell |
2,140
-325
| -13% | -$42.3K | 0.02% | 344 |
|
|
2021
Q4 | $376K | Sell |
2,465
-807
| -25% | -$125K | 0.01% | 394 |
|
|
2021
Q3 | $529K | Buy |
3,272
+262
| +9% | +$44.1K | 0.02% | 330 |
|
|
2021
Q2 | $493K | Sell |
3,010
-10
| -0.3% | -$1.54K | 0.03% | 272 |
|
|
2021
Q1 | $454K | Buy |
3,020
+818
| +37% | +$130K | 0.03% | 274 |
|
|
2020
Q4 | $334K | Sell |
2,202
-223
| -9% | -$31.9K | 0.02% | 266 |
|
|
2020
Q3 | $328K | Sell |
2,425
-45
| -2% | -$6.11K | 0.02% | 256 |
|
|
2020
Q2 | $337K | Sell |
2,470
-450
| -15% | -$57.4K | 0.03% | 240 |
|
|
2020
Q1 | $315K | Buy |
2,920
+350
| +14% | +$40.3K | 0.03% | 229 |
|
|
2019
Q4 | $309K | Hold |
2,570
| – | – | 0.02% | 280 |
|
|
2019
Q3 | $255K | Hold |
2,570
| – | – | 0.02% | 291 |
|
|
2019
Q2 | $280K | Sell |
2,570
-676
| -21% | -$71.9K | 0.02% | 294 |
|
|
2019
Q1 | $362K | Buy |
3,246
+40
| +1% | +$4.39K | 0.03% | 253 |
|
|
2018
Q4 | $309K | Sell |
3,206
-111
| -3% | -$11.8K | 0.03% | 273 |
|
|
2018
Q3 | $404K | Sell |
3,317
-1,170
| -26% | -$138K | 0.03% | 271 |
|
|
2018
Q2 | $493K | Buy |
4,487
+600
| +15% | +$64.2K | 0.04% | 248 |
|
|
2018
Q1 | $414K | Buy |
3,887
+200
| +5% | +$22.2K | 0.04% | 218 |
|
|
2017
Q4 | $394K | Buy |
3,687
+192
| +5% | +$20.5K | 0.04% | 231 |
|
|
2017
Q3 | $389K | Sell |
3,495
-750
| -18% | -$80.2K | 0.04% | 226 |
|
|
2017
Q2 | $439K | Buy |
4,245
+2,310
| +119% | +$228K | 0.05% | 213 |
|
|
2017
Q1 | $189K | Buy |
+1,935
| New | +$185K | 0.02% | 323 |
|
Other funds holding IBB
CB
First Horizon Advisors's IBB Position: Q2 2025 in Review
First Horizon Advisors reduced its iShares Biotechnology ETF (IBB) stake by 27% in Q2 2025, selling an estimated $104K and leaving 2,331 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #438.
First Horizon Advisors first reported a position in IBB in Q1 2017 and has held it in 34 quarters since. The position peaked at $529K in Q3 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- First Horizon Advisors held 2,331 shares of iShares Biotechnology ETF worth $295K as of Q2 2025.
- First Horizon Advisors sold 850 iShares Biotechnology ETF shares in Q2 2025, an estimated $104K.
- iShares Biotechnology ETF made up 0.01% of First Horizon Advisors's portfolio in Q2 2025, its #438 holding.
- First Horizon Advisors first reported a position in iShares Biotechnology ETF in Q1 2017 and has held it in 34 quarters since.
- First Horizon Advisors's iShares Biotechnology ETF position peaked at $529K in Q3 2021.
- 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.